Lantern Pharma (LTRN) Interest & Investment Income (2021 - 2026)
Lantern Pharma (LTRN) posted Interest & Investment Income of $30,079 for Q2 2026, down 73.8% from $114,745 a year earlier and down 28.7% from the prior quarter.
Powered by 
Analysis
Lantern Pharma (LTRN) Interest & Investment Income (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Lantern Pharma was $245,635, down 60.2% year-over-year; for FY2025, it was $437,931, down 41.0% from FY2024.
- Annual Interest & Investment Income shows a four-year compound annual growth rate of 59.3% (FY2021 to FY2025).
- In prior years, Lantern Pharma's Interest & Investment Income was $742,355 in FY2024 (-3.0%), $765,388 in FY2023 (+274.5%), $204,355 in FY2022 (+200.8%) and $67,929 in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Interest & Investment Income since Q1 2022.
- On a year-over-year basis, Interest & Investment Income has declined in each of the last eight quarters, with an average decline of 46.8% over the last eight quarters.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q1 2023, with growth of 496.7%; the weakest was Q2 2026, with a decline of 73.8%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $42,160 (Q1 2026), $72,475 (Q4 2025) and $100,921 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | - |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | - |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | - |
| 10 | Lantern Pharma | 7.95 Mn | -28.21 Mn | - | 30,079.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30,079.00 |
| Mar 31, 2026 | 42,160.00 |
| Dec 31, 2025 | 72,475.00 |
| Sep 30, 2025 | 100,921.00 |
| Jun 30, 2025 | 114,745.00 |
| Mar 31, 2025 | 149,790.00 |
| Dec 31, 2024 | 161,393.00 |
| Sep 30, 2024 | 191,352.00 |
| Jun 30, 2024 | 188,660.00 |
| Mar 31, 2024 | 200,950.00 |
| Dec 31, 2023 | 267,389.00 |
| Sep 30, 2023 | 246,394.00 |
| Jun 30, 2023 | 117,823.00 |
| Mar 31, 2023 | 133,782.00 |
| Dec 31, 2022 | 74,684.00 |
| Sep 30, 2022 | 52,224.00 |
| Jun 30, 2022 | 55,026.00 |
| Mar 31, 2022 | 22,421.00 |
| Dec 31, 2021 | -57,179.00 |
| Sep 30, 2021 | 77,219.00 |
API Access
Lantern Pharma Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LTRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "LTRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LTRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();